These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1506656

  • 1. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis.
    Lee FY, Tsai YT, Lin HC, Lee SD, Hsia HC, Lin WJ, Wang SS, Lai KH, Lo KJ.
    J Hepatol; 1992 May; 15(1-2):54-8. PubMed ID: 1506656
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee WC, Lee FY, Chang FY, Lee SD.
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [Abstract] [Full Text] [Related]

  • 5. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J, Kravetz D, Rodes J.
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
    Mols P, Hallemans R, Van Kuyk M, Melot C, Lejeune P, Ham H, Vertongen F, Naeije R.
    Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
    [Abstract] [Full Text] [Related]

  • 7. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
    Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Sakaki M, Shigemori H, Nakayama M, Sasaki E, Tanikawa K.
    J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
    [Abstract] [Full Text] [Related]

  • 8. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
    Groszmann RJ, Kravetz D, Bosch J, Glickman M, Bruix J, Bredfeldt J, Conn HO, Rodes J, Storer EH.
    Hepatology; 1982 Nov; 2(6):757-62. PubMed ID: 6815044
    [Abstract] [Full Text] [Related]

  • 9. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
    Hallemans R, Naeije R, Mols P, Mélot C, Reding P.
    Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
    [Abstract] [Full Text] [Related]

  • 10. Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients.
    Sirinek KR, Thomford NR.
    Am J Surg; 1975 Feb; 129(2):130-6. PubMed ID: 1078945
    [Abstract] [Full Text] [Related]

  • 11. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
    Westaby D, Gimson A, Hayes PC, Williams R.
    Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
    [Abstract] [Full Text] [Related]

  • 12. [Effect of a serotonin S2 receptor antagonist on portal hypertension due to cirrhosis. Preliminary results of a heart and liver hemodynamic study].
    Deflandre J, Pirotte J, Etienne M, Carlier J.
    Ann Gastroenterol Hepatol (Paris); 1988 Mar; 24(3):103-5. PubMed ID: 3400992
    [Abstract] [Full Text] [Related]

  • 13. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
    Barr JW, Lakin RC, Rösch J.
    Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
    [Abstract] [Full Text] [Related]

  • 14. Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension.
    Hadengue A, Lee SS, Moreau R, Braillon A, Lebrec D.
    Hepatology; 1987 Jul; 7(4):644-7. PubMed ID: 3610044
    [Abstract] [Full Text] [Related]

  • 15. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R, Soubrane O, Hadengue A, Sogni P, Gaudin C, Kleber G, Lebrec D.
    Gastroenterol Clin Biol; 1992 Jul; 16(8-9):680-6. PubMed ID: 1426824
    [Abstract] [Full Text] [Related]

  • 16. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
    Rector WG, Hossack KF.
    J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
    [Abstract] [Full Text] [Related]

  • 17. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
    Hadengue A, Moreau R, Cerini R, Koshy A, Lee SS, Lebrec D.
    Hepatology; 1989 Jan; 9(1):83-7. PubMed ID: 2908872
    [Abstract] [Full Text] [Related]

  • 18. Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients.
    Vorobioff J, Garcia-Tsao G, Groszmann R, Aceves G, Picabea E, Villavicencio R, Hernandez-Ortiz J.
    Hepatology; 1989 Jan; 9(1):88-91. PubMed ID: 2908873
    [Abstract] [Full Text] [Related]

  • 19. Effects of octreotide on postprandial systemic and hepatic hemodynamics in patients with postnecrotic cirrhosis.
    Lin HC, Tsai YT, Huang CC, Meng HC, Lee FY, Wang SS, Lee SD, Lo KJ.
    J Hepatol; 1994 Sep; 21(3):424-9. PubMed ID: 7836713
    [Abstract] [Full Text] [Related]

  • 20. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
    Iwao T, Toyonaga A, Ikegami M, Sumino M, Oho K, Sakaki M, Nishizono M, Tanikawa K.
    Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.